Spineology Receives FDA Clearance for Rampart Interbody Fusion Devices

Spineology, a St. Paul, Minn.-based spine device company, has received FDA clearance for its Rampart line of interbody fusion implants, according to a Spineology news release. The company will now initiate a launch of the product line, which includes a variety of implant configurations to fit different patient anatomy. The implantation equipment is designed to enhance the surgeon's ability to position the implant within the disc space.

Related Articles on Spine Devices:
Spine Device Company Medicrea International Reports Revenue Growth
Spinal USA Expands, Creates Jobs
Spineology to Launch SOAR Retractor System